Prof. Wen Jen Lin, Applied Chemistry, Best Researcher Award

Professor at National Taiwan University, Taiwan

Professional Profiles

🎓 Academic and Professional Background

Dr. Wen Jen Lin is a distinguished scholar in the field of pharmacy, holding a Ph.D. in Pharmaceutics from the University of Iowa, USA, and an M.S. in Pharmacokinetics from the School of Pharmacy at National Taiwan University. Dr. Lin currently serves as a Professor at the School of Pharmacy and as the Leader of the Pharmaceutical Research Group in the Drug Research Center at the College of Medicine, National Taiwan University.

🧑‍🔬 Professional Experience and Contributions

Throughout his career, Dr. Lin has made substantial contributions to both academia and the pharmaceutical industry. His roles include serving on advisory committees for Food and Drug Administration (Ministry of Health and Welfare), as a consultant for the Center for Drug Evaluation, and as an editorial board member for the Asian Journal of Pharmaceutical Sciences. He has also been a reviewer for major institutions such as the Council of Agriculture and Ministry of Science and Technology.

🏆 Honors and Awards

Dr. Lin’s expertise and dedication have been widely recognized through multiple awards, including the Senior Teacher Award (2000, 2010), the Ching-Kang Foundation Young Teacher Award (2004), and the Research Award for Academic Performance from National Taiwan University, awarded across multiple years (2007-2010, 2012-2022, 2024). Notably, he was honored with the Professor Li Jhao Ren Foundation Research Scholar Award in 2017, underlining his research impact.

👥 Professional Memberships

Dr. Lin is a permanent member of various esteemed organizations, including The Pharmaceutical Society of Taiwan, Biomaterials and Controlled Release Society of Taiwan, and Taiwan Parenteral Drug Association. His recent affiliation with The Pharmaceutical Society of Japan (2024) highlights his expanding global influence.

🔬 Areas of Research

Dr. Lin’s research specialties span nanomedicine, cancer therapy, pharmacokinetics, and biomaterials, focusing on solutions to critical clinical needs. His early work developed porous polymeric microparticles for protein release, exploring “green synthesis” methods that avoid toxic catalysts. Dr. Lin’s middle-stage research synthesized amphiphilic copolymers forming micelles for drug delivery, which he adapted for targeted therapies in liver and cancer treatment. In recent studies, he addresses challenges in glioma therapy, engineering nanoparticles capable of crossing the blood-brain barrier (BBB) for targeted delivery. Additionally, his innovative oral nanoparticle platform for acid-labile drugs presents promising advancements in gastroesophageal reflux disease treatment, improving bioavailability and sustained drug release.

Publications Top Noted📝

Zein-PEG nanoparticles modified with hyaluronic acid for paclitaxel delivery in SKOV3 ovarian cancer cells

Authors: Lai, M.-H., Lin, W.-J.
Journal: International Journal of Biological Macromolecules
Year: 2024

Improve BBB Penetration and Cytotoxicity of Palbociclib in U87-MG Glioblastoma Cells Delivered by Dual Peptide Functionalized Nanoparticles

Authors: Lo, Y.-C., Lin, W.-J.
Journal: Pharmaceutics
Year: 2023

Synergistic cytotoxicity of irinotecan combined with polysaccharide-based nanoparticles for colorectal carcinoma

Authors: Pai, F.-T., Lin, W.-J.
Journal: Biomaterials Advances
Year: 2023

Benefit of a short chain peptide as a targeting ligand of nanocarriers for a brain-driven purpose

Authors: Lo, Y.-C., Lin, W.-J.
Journal: Pharmaceutics
Year: 2021

Peptide-functionalized nanoparticles-encapsulated cyclin-dependent kinases inhibitor seliciclib in transferrin receptor overexpressed cancer cells

Authors: He, G.Z., Lin, W.-J.
Journal: Nanomaterials
Year: 2021

Dr. sherif Hosny, Medicinal Chemistry, Best Researcher Award

Doctorate at EHA, Egypt

Professional Profiles

Google Scholar

Scopus

🎓 Educational Background

He attended German School Dokki, Cairo from 1984 to 1994, achieving his Abitur with a grade of 1.9. From 1994 to 1998, he studied at the Faculty of Pharmacy, Cairo University, where he earned a Bachelor’s Degree in Pharmaceutical Science, graduating with Excellent with honors.In March 2000, he began his postgraduate studies at the Faculty of Pharmacy, Cairo University, registering for a Master’s degree in pharmaceutical science, specializing in the pharmacognosy department. His research focused on the topic: “A Contribution to the Study of Certain Hepatoprotective Plants Belonging to Family Apiaceae and Asteraceae.” Between 2005 and 2007, he completed a Diploma in Health Care Administration at the American University in Cairo.

In April 2008, he participated in a Fellowship at St. Jude Children’s Hospital. In September 2010, he registered for an MSc in Clinical Pharmacy at the Faculty of Pharmacy, Cairo University. He furthered his education by attending the Basis and Intermediate Master Class in Oncology Pharmacy in Vienna, Austria in October 2012, followed by the Advanced Master Class in Oncology Pharmacy in Dresden, Germany in October 2013.He obtained a Master’s Degree in Pharmaceutical Science, specializing in Clinical Pharmacy from the Faculty of Pharmacy, Cairo University in September 2015. His thesis was titled: “The Use of Valproic Acid in Pediatric Oncology Setting.” In 2016, he became a Certified Professional Trainer through the American University in Cairo. Finally, in September 2018, he became a PhD Candidate in Pharmaceutical Science, specializing in Clinical Pharmacy. His research topic is: “Evaluation of Antimicrobial Stewardship Program in Pediatric Oncology.”

🏆 Awards

He has received several prestigious awards, including the German President Award for Students, an Award from the Egyptian Hospital Pharmacist Association, and the First Lady Award for Excellence in 2010. He was recognized at the 1st Student Development Conference at Sinai University in 2010 and received the Egyptian Pharmacy Syndicate Award in the same year. Most recently, he earned the Best Pharmacist Award in 2018 from the Egyptian Pharmacy Syndicate CME Committee.

💼 Work Experience

From May 1998 to September 2002, he worked as a Clinical Pharmacist at the National Cancer Institute, Cairo University. His key responsibilities included the I.V. admixture of antibiotics and cytotoxic agents, leading the Clinical Pharmacy Development Program, and serving as the Senior Clinical Pharmacist and Night Shift Manager. His achievements include establishing Policies, Procedures, and Guidelines for the Oncology Clinical Pharmacy and overseeing operations as Senior Pharmacist.From 1999 to 2006, he served as a Senior Clinical Pharmacy Consultant at the Domiatta Cancer Institute, Egyptian Ministry of Health, where he managed the Clinical Pharmacy Development Program and established a protocol book for oncology clinical practices. He directed Annual Strategic Planning for clinical pharmacy services.

He also worked at the Tanta Cancer Institute and Menia Cancer Institute as a Senior Clinical Pharmacy Consultant from 1999 to 2000, leading the Clinical Pharmacy Development Program and training nursing staff in oncology pharmacy practices. His achievements included developing Oncology Clinical Pharmacy Guidelines and designing an Oncology Nurse Training Program.From 2001 to 2007, he continued as a Senior Clinical Pharmacy Consultant at the Sohag Cancer Institute, where he led the Clinical Pharmacy Development Program and developed a protocol book, directing Annual Strategic Planning and establishing policies for oncology pharmacy.

From 2008 to 2009, he worked at Frensh Qasr El Eini, Cairo University, where he managed the Clinical Pharmacy Development Program and created a protocol book, implementing clinical pharmacy policies and planning procedures.Finally, from April 1999 to 2006, he was a Teaching Assistant in the Pharmacognosy Department at the Faculty of Pharmacy, Cairo University (Beni Suef). His responsibilities included preparing lab equipment, delivering lectures, and supervising students. His achievements enhanced Pharmacognosy teaching methods and improved student engagement.

publications Top Noted📄

SIOPE and ESOP recommendations for extemporaneous compounding of oral liquid medicine formulations in pediatric oncology

Authors: Otsokolhich, M., Annereau, M., Bauters, T., Vassal, G., Buraja, S.

Journal: EJC Paediatric Oncology

Year: 2024

Correlation of Genetic Polymorphism of CYP3A5 to Cyclophosphamide Efficacy and Toxicity in Rhabdomyosarcoma Pediatric Egyptian Cancer Patients

Authors: ElShereef, C.E., Zaki, H.F., Badary, O.A., El Naga, S.A., Saber, M.M.

Journal: Asian Pacific Journal of Cancer Prevention

Year: 2024

Optimizing vancomycin therapeutic drug monitoring compliance in pediatric oncology: towards personalized medication management

Authors: Mohamed, R.G., Saber, R., Hussein, M.A., Shalaby, L., Nagy, M.

Journal: Personalized Medicine

Year: 2024

Efficacy and Toxicity of Vincristine and CYP3A5 Genetic Polymorphism in Rhabdomyosarcoma Pediatric Egyptian Patients

Authors: Shalaby, N., Zaki, H.F., Badary, O.A., Abouelnaga, S., Saber, M.M.

Journal: Asian Pacific Journal of Cancer Prevention

Year: 2024

Current status of African pediatric oncology education efforts aligned with the Global Initiative for Childhood Cancer

Authors: van Heerden, J., Lisa Christine, I., Downing, J., Balagadde-Kambugu, J., Geel, J.

Journal: Pediatric Hematology and Oncology

Year: 2023